Sign in

CIK 0001819133

  • Non-accelerated filer
  • Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,938,345
in 7 filings, $1.9M under 10b5-1 plans

Net −$1,938,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-08 Peters Malte President & CEO Grant or award +350,000 367,500
2026-01-08 Peters Malte President & CEO Grant or award · Stock Option (Right to Buy) +1,650,000 1,650,000
2025-11-03 Peters Malte Director Grant or award · Stock Option (Right to Buy) +150,000 150,000
2025-06-05 Peters Malte Director Grant or award +6,250 17,500
2025-06-05 Peters Malte Director Grant or award · Stock Option (Right to Buy) +37,500 37,500
2024-06-05 Peters Malte Director Grant or award +6,250 11,250
2024-06-05 Peters Malte Director Grant or award · Stock Option (Right to Buy) +37,500 37,500
2023-06-06 Peters Malte Director Grant or award +5,000 5,000
2023-06-06 Peters Malte Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-06-08 Peters Malte Director Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 1 of 1 · 10 trades